On Oct 1, 2021 Latch Bio closed a Seed round and raised $5,000,000 from Asimov, Fifty Years, General Catalyst, Haystack, Lux Capital, featuring lead investors Lux Capital.
About the company: Latch Bio is located at United States, North America.
“The command center for all gene-editing bioinformatics. Analyze your CRISPR data without code in 5 minutes.”
Company website: http://www.latch.bio